Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 30, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 2, 2026
CEOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001635088-26-000034
Filed / recorded
Apr 2, 2026, 3:20 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Roivant Sciences Ltd.
Issuer CIK
1635088
Ticker
ROIV
Reporting person
Matthew Gline
Relationship
Director, Officer
Officer title
CEO
Security
Common Shares
Table
Non-derivative (Table I)
Transaction date
Mar 30, 2026
Transaction code
F
Shares / units
53,826
Price per share
$26.41
Acquired / disposed
Disposed (D)
Shares owned after
17,330,574
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the "net settlement" by the Issuer of CVARs in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such CVARs.